Lallemand Pharma

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Lallemand Pharma
Lallemand
  1. Lallemand Pharma
  2. New COPD clinical study shows efficacy of PMBLTM to reduce infection risks in patients by almost 3 -fold and further substantiate its immunostimulatory capacity

News details

Nov
12,
2013

New COPD clinical study shows efficacy of PMBLTM to reduce infection risks in patients by almost 3 -fold and further substantiate its immunostimulatory capacity

Nov 12, 2013

© 2024 Lallemand Inc. All right reserved